Another study screened the CHEK2 coding sequence of 118 cases of Chinese FBC negative for BRCA1 and BRCA2 mutations and confirmed that the incidence of CHEK2 c.1111C>T in FBC was higher than that in non-selective BC (4.24% vs. 1.76%) (106). This evidence concerns the gene BRCA2 and breast cancer.